(Q33326620)

25 July 2017

title

Low vs. high radioiodine activity to ablate the thyroid after thyroidectomy for cancer: a randomized study (English)

1 reference

25 July 2017

Hanna O Mäenpää

1

1 reference

25 July 2017

Jorma Heikkonen

2

1 reference

25 July 2017

Leila Vaalavirta

3

1 reference

25 July 2017

Mikko Tenhunen

4

1 reference

25 July 2017

Heikki Joensuu

5

1 reference

25 July 2017

language of work or name

English

0 references

publication date

2 April 2008

1 reference

25 July 2017

1 reference

25 July 2017

volume

3

1 reference

25 July 2017

issue

4

1 reference

25 July 2017

page(s)

e1885

1 reference

Creative Commons Attribution 4.0 International

25 July 2017

copyright license

start time

2 April 2008

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

131I activity for remnant ablation in patients with differentiated thyroid cancer: A systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270902

Second primary cancers in thyroid cancer patients: a multinational record linkage study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270902

Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270902

Post-surgical use of radioiodine (131I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus report

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270902

Second primary malignancies in thyroid cancer patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270902

Randomized trials on radioactive iodine ablation of thyroid remnants for thyroid carcinoma--a critique

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270902

Quantitative external counting techniques enabling improved diagnostic and therapeutic decisions in patients with well-differentiated thyroid cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270902

131I therapy for differentiated thyroid cancer leads to an earlier onset of menopause: results of a retrospective study

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0001885

Clinical comparison of whole-body radioiodine scan and serum thyroglobulin after stimulation with recombinant human thyrotropin.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0001885

[Early evaluation of treatment effectiveness using 131I iodine radiotherapy in patients with differentiated thyroid cancer]

21 January 2018

1 reference

12 December 2020

Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer

1 reference

12 December 2020

Serum thyroglobulin and 131I whole body scan after recombinant human TSH stimulation in the follow-up of low-risk patients with differentiated thyroid cancer

1 reference

12 December 2020

Management guidelines for patients with thyroid nodules and differentiated thyroid cancer

1 reference

12 December 2020

High or low dose radioiodine ablation of thyroid remnants?

1 reference

12 December 2020

Radioiodine dose for remnant ablation in differentiated thyroid carcinoma: a randomized clinical trial in 509 patients

1 reference

12 December 2020

1 reference

12 December 2020

Prospective randomized clinical trial to evaluate the optimal dose of 131 I for remnant ablation in patients with differentiated thyroid carcinoma

1 reference

12 December 2020

Testicular function in patients with differentiated thyroid carcinoma treated with radioiodine

1 reference

12 December 2020

Comparison of 1073 MBq and 3700 MBq iodine-131 in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid cancer

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0001885

Identifiers

DOI

1 reference

25 July 2017

0 references

1 reference

25 July 2017

1 reference